Expert perspectives on the design and communication of endpoints in Alzheimer's disease clinical trials.

Pierre N Tariot; Samuel P Dickson; John Dwyer; Carlos Granda; Lynne Hughes; Jason Karlawish; Nicklas Linz; Kavita V Nair; Russ Paulsen; Daniel Pawson; Robert Perneczky; Suzanne E Schindler; Emily Scholler; James Taylor; Benjamin Tiede; George Vradenburg

doi:10.1002/alz.71951

SCHEDA SCIENTIFICA2026Altra ricerca

Expert perspectives on the design and communication of endpoints in Alzheimer's disease clinical trials.

Pierre N Tariot, Samuel P Dickson, John Dwyer, Carlos Granda, Lynne Hughes, Jason Karlawish, Nicklas Linz, Kavita V Nair, Russ Paulsen, Daniel Pawson, Robert Perneczky, Suzanne E Schindler, Emily Scholler, James Taylor, Benjamin Tiede, George Vradenburg

Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026

Psicologia clinica Psicoterapia

Abstract e pubblicazione originale

L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.

Leggi nella fonte originale ↗

Parole chiave

Alzheimer DiseaseHumansClinical Trials as TopicEndpoint DeterminationCommunicationResearch DesignAlzheimer's diseaseClinical trialclinical careclinical developmentclinical practicedementiadisease‐targeting treatmentendpointendpoint designmild cognitive impairmentpatientpatient‐centeredpreventiontreatmenttreatment outcomes

Come citare questo studio

Pierre N Tariot, Samuel P Dickson, John Dwyer, Carlos Granda, Lynne Hughes, Jason Karlawish, Nicklas Linz, Kavita V Nair, Russ Paulsen, Daniel Pawson, Robert Perneczky, Suzanne E Schindler, Emily Scholler, James Taylor, Benjamin Tiede, George Vradenburg. (2026). Expert perspectives on the design and communication of endpoints in Alzheimer's disease clinical trials.. Alzheimer's & dementia : the journal of the Alzheimer's Association. DOI: 10.1002/alz.71951

Consulta la pubblicazione originale ↗